Phase I Study of Safety and Pharmacokinetics of Once-Daily Topical Solution in Male Subjects With Androgenetic Alopecia
Latest Information Update: 25 May 2023
At a glance
- Drugs Latanoprost/minoxidil (Primary)
- Indications Alopecia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Aneira Pharma
- 25 May 2023 New trial record